JCML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia (NCT05849662) | Therapeutic Advances in Childhood Leukemia Consortium | 2024-10-11 |
Track JCML automatically
Every clearance here is in the API, with alerts when new ones post.